Chilton Capital Management’s Novartis NVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $1.14M | Sell |
7,290
-2
| -0% | -$300 | 0.04% | 123 |
|
|
2026
Q1 | $1.11M | Sell |
7,292
-597
| -8% | -$91.5K | 0.04% | 123 |
|
|
2025
Q4 | $1.09M | Sell |
7,889
-731
| -8% | -$95.7K | 0.04% | 125 |
|
|
2025
Q3 | $1.11M | Sell |
8,620
-1,210
| -12% | -$148K | 0.04% | 132 |
|
|
2025
Q2 | $1.19M | Sell |
9,830
-72
| -0.7% | -$8.12K | 0.04% | 123 |
|
|
2025
Q1 | $1.1M | Sell |
9,902
-385
| -4% | -$41K | 0.05% | 121 |
|
|
2024
Q4 | $1M | Sell |
10,287
-413
| -4% | -$44K | 0.04% | 129 |
|
|
2024
Q3 | $1.23M | Sell |
10,700
-70
| -0.6% | -$7.94K | 0.05% | 123 |
|
|
2024
Q2 | $1.15M | Sell |
10,770
-618
| -5% | -$62K | 0.05% | 123 |
|
|
2024
Q1 | $1.1M | Buy |
11,388
+708
| +7% | +$72.6K | 0.05% | 123 |
|
|
2023
Q4 | $1.08M | Sell |
10,680
-10
| -0.1% | -$965 | 0.05% | 125 |
|
|
2023
Q3 | $1.09M | Sell |
10,690
-53
| -0.5% | -$5.38K | 0.06% | 117 |
|
|
2023
Q2 | $1.08M | Sell |
10,743
-32
| -0.3% | -$3.2K | 0.06% | 121 |
|
|
2023
Q1 | $991K | Sell |
10,775
-917
| -8% | -$80.1K | 0.06% | 122 |
|
|
2022
Q4 | $1.06M | Buy |
11,692
+191
| +2% | +$16.1K | 0.07% | 125 |
|
|
2022
Q3 | $874K | Buy |
11,501
+1,167
| +11% | +$96.7K | 0.06% | 127 |
|
|
2022
Q2 | $874K | Sell |
10,334
-92
| -0.9% | -$8.07K | 0.05% | 130 |
|
|
2022
Q1 | $914K | Buy |
10,426
+2,265
| +28% | +$196K | 0.05% | 133 |
|
|
2021
Q4 | $714K | Sell |
8,161
-410
| -5% | -$34K | 0.04% | 148 |
|
|
2021
Q3 | $701K | Buy |
8,571
+1,649
| +24% | +$148K | 0.04% | 145 |
|
|
2021
Q2 | $632K | Sell |
6,922
-135,564
| -95% | -$12.1M | 0.04% | 147 |
|
|
2021
Q1 | $12.2M | Sell |
142,486
-8,368
| -6% | -$751K | 0.81% | 56 |
|
|
2020
Q4 | $14.2M | Sell |
150,854
-144
| -0.1% | -$12.6K | 1.02% | 47 |
|
|
2020
Q3 | $13.1M | Buy |
150,998
+10,200
| +7% | +$884K | 1.02% | 39 |
|
|
2020
Q2 | $12.3M | Buy |
140,798
+5,612
| +4% | +$484K | 1.05% | 40 |
|
|
2020
Q1 | $11.1M | Buy |
135,186
+4,654
| +4% | +$415K | 1.12% | 34 |
|
|
2019
Q4 | $12.4M | Sell |
130,532
-466
| -0.4% | -$41.8K | 0.98% | 48 |
|
|
2019
Q3 | $11.4M | Buy |
130,998
+286
| +0.2% | +$25.7K | 0.94% | 52 |
|
|
2019
Q2 | $11.9M | Sell |
130,712
-16,977
| -11% | -$1.44M | 1.02% | 45 |
|
|
2019
Q1 | $12.7M | Buy |
147,689
+2,448
| +2% | +$197K | 1.13% | 34 |
|
|
2018
Q4 | $11.2M | Buy |
145,241
+4,600
| +3% | +$358K | 1.08% | 33 |
|
|
2018
Q3 | $10.9M | Sell |
140,641
-2,435
| -2% | -$180K | 0.9% | 48 |
|
|
2018
Q2 | $9.67M | Buy |
143,076
+2,823
| +2% | +$195K | 0.83% | 58 |
|
|
2018
Q1 | $10.1M | Buy |
140,253
+135,488
| +2,843% | +$10.3M | 0.92% | 51 |
|
|
2017
Q4 | $359K | Buy |
4,765
+304
| +7% | +$22.9K | 0.03% | 147 |
|
|
2017
Q3 | $343K | Sell |
4,461
-39
| -0.9% | -$2.94K | 0.03% | 141 |
|
|
2017
Q2 | $337K | Sell |
4,500
-77,491
| -95% | -$5.49M | 0.04% | 131 |
|
|
2017
Q1 | $5.46M | Sell |
81,991
-3,641
| -4% | -$243K | 0.54% | 68 |
|
|
2016
Q4 | $5.59M | Sell |
85,632
-9,580
| -10% | -$621K | 0.58% | 65 |
|
|
2016
Q3 | $6.74M | Sell |
95,212
-4,152
| -4% | -$303K | 0.68% | 60 |
|
|
2016
Q2 | $7.35M | Sell |
99,364
-2,881
| -3% | -$199K | 0.71% | 59 |
|
|
2016
Q1 | $6.64M | Sell |
102,245
-7,799
| -7% | -$531K | 0.66% | 63 |
|
|
2015
Q4 | $8.48M | Buy |
110,044
+2,238
| +2% | +$178K | 0.89% | 42 |
|
|
2015
Q3 | $8.88M | Sell |
107,806
-11,918
| -10% | -$1.06M | 0.91% | 45 |
|
|
2015
Q2 | $10.6M | Buy |
119,724
+1,456
| +1% | +$134K | 0.99% | 37 |
|
|
2015
Q1 | $10.4M | Sell |
118,268
-6,663
| -5% | -$591K | 1.05% | 36 |
|
|
2014
Q4 | $10.4M | Sell |
124,931
-5,816
| -4% | -$482K | 1.05% | 34 |
|
|
2014
Q3 | $11M | Buy |
130,747
+1,555
| +1% | +$126K | 1.17% | 28 |
|
|
2014
Q2 | $10.5M | Buy |
129,192
+3,131
| +2% | +$246K | 1.02% | 37 |
|
|
2014
Q1 | $9.6M | Buy |
126,061
+3,750
| +3% | +$273K | 1.01% | 38 |
|
|
2013
Q4 | $8.81M | Buy |
122,311
+30,349
| +33% | +$2.11M | 0.95% | 39 |
|
|
2013
Q3 | $6.32M | Sell |
91,962
-833
| -0.9% | -$55.1K | 0.72% | 52 |
|
|
2013
Q2 | $5.88M | Buy |
+92,795
| New | +$6.04M | 0.73% | 53 |
|
Other funds holding NVS
Chilton Capital Management's NVS Position: Q2 2026 in Review
Chilton Capital Management reduced its Novartis (NVS) stake by 0.03% in Q2 2026, selling an estimated $300 and leaving 7,290 shares worth $1.14M. The position accounts for 0.04% of the portfolio, ranked #123.
Chilton Capital Management first reported a position in NVS in Q2 2013 and has held it in 53 quarters since. The position peaked at $14.2M in Q4 2020. 1,617 funds tracked by Wall St. Rank hold NVS as of Q2 2026.
- Chilton Capital Management held 7,290 shares of Novartis worth $1.14M as of Q2 2026.
- Chilton Capital Management sold 2 Novartis shares in Q2 2026, an estimated $300.
- Novartis made up 0.04% of Chilton Capital Management's portfolio in Q2 2026, its #123 holding.
- Chilton Capital Management first reported a position in Novartis in Q2 2013 and has held it in 53 quarters since.
- Chilton Capital Management's Novartis position peaked at $14.2M in Q4 2020.
- 1,617 funds tracked by Wall St. Rank held Novartis as of Q2 2026.
Based on Chilton Capital Management's 13F filing for Q2 2026, filed 4 Aug 2026.